Alto Neuroscience, Inc.
ANRO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $164 | $100 | $0 | $170 |
| Gross Profit | -$164 | -$100 | $0 | -$170 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,525 | $13,124 | $9,974 | $10,800 |
| G&A Expenses | $0 | $5,558 | $5,702 | $0 |
| SG&A Expenses | $4,262 | $5,558 | $5,702 | $6,027 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$100 | $0 | $0 |
| Operating Expenses | $14,787 | $18,582 | $15,676 | $16,827 |
| Operating Income | -$14,951 | -$18,682 | -$15,676 | -$16,997 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $770 | $976 | $507 | $1,796 |
| Pre-Tax Income | -$14,181 | -$17,706 | -$15,169 | -$15,201 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14,181 | -$17,706 | -$15,169 | -$15,201 |
| % Margin | – | – | – | – |
| EPS | -0.52 | -0.65 | -0.56 | -0.56 |
| % Growth | 20% | -16.1% | 0% | – |
| EPS Diluted | -0.52 | -0.65 | -0.56 | -0.56 |
| Weighted Avg Shares Out | 27,104 | 27,072 | 27,049 | 26,987 |
| Weighted Avg Shares Out Dil | 27,104 | 27,072 | 27,049 | 26,987 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,532 | $1,683 | $1,827 | $2,135 |
| Interest Expense | $650 | $646 | $598 | $333 |
| Depreciation & Amortization | $164 | $100 | $171 | $170 |
| EBITDA | -$13,367 | -$16,960 | -$14,400 | -$14,698 |
| % Margin | – | – | – | – |